JPMorgan raises Regeneron Pharmaceuticals (REGN.US) target price to $950

智通财经2026/10/06 04:41

Show original

JPMorgan has raised the price target for Regeneron Pharmaceuticals (REGN.US) from $900 to $950.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

New York crude oil OTC price exceeds $91, rising more than 0.1% intraday.

智通财经•2026/10/10 23:16

UK maritime authorities report emergency incident in the Strait of Hormuz

智通财经•2026/10/10 22:46

The U.S. Department of Energy authorizes the Strategic Petroleum Reserve to swap up to 4 million barrels of crude oil.

智通财经•2026/10/10 19:46

ExxonMobil and BP can allocate up to 2 million barrels of crude oil between each other

智通财经•2026/10/10 19:46